Daytona Street Capital’s Viemed Healthcare VMD Stock Holding History

Daytona Street Capital’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66K	Hold	300	–	–	﹤0.01%	259
2026 Q1	$2.9K	Hold	300	–	–	﹤0.01%	285
2025 Q4	$2.23K	Buy	+300	New	+$2.06K	﹤0.01%	286

Other funds holding VMD

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SIM

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Daytona Street Capital's VMD Position: Q2 2026 in Review

Daytona Street Capital held its Viemed Healthcare (VMD) position steady in Q2 2026 at 300 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Daytona Street Capital first reported a position in VMD in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Daytona Street Capital held 300 shares of Viemed Healthcare worth $3.66K as of Q2 2026.
Daytona Street Capital left its Viemed Healthcare share count unchanged in Q2 2026.
Viemed Healthcare made up ﹤0.01% of Daytona Street Capital's portfolio in Q2 2026, its #259 holding.
Daytona Street Capital first reported a position in Viemed Healthcare in Q4 2025 and has held it in 3 quarters since.
55 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.